Clinical trial
Apelin as a Marker of Early Complications in Type 1 Diabetes Mellitus
NCT05738577 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apelin as a Marker of Early Complications in Type 1 Diabetes Mellitus
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 25, 2023
- Completion date
- December 1, 2025
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.